Managing and mining sensor data

Por Aggarwal, Charu C.
Publicado em 2013

Outlier analysis

Por Aggarwal, Charu C.
Publicado em 2013

Managing and mining uncertain data

Por Aggarwal, Charu C.
Publicado em 2009

Data streams models and algorithms /

Por Aggarwal, Charu C.
Publicado em 2007

Social network data analytics

Por Aggarwal, Charu C.
Publicado em 2011

Rational use of cetuximab in the treatment of advanced non-small cell lung cancer

Por Aggarwal, Charu, Borghaei, Hossein
Publicado em 2009

Privacy-preserving data mining models and algorithms /

Por Aggarwal, Charu C., Yu, Philip S.
Publicado em 2008

Managing and mining graph data

Por Aggarwal, Charu C., Wang, Haixun
Publicado em 2010

Mining text data

Por Aggarwal, Charu C., Zhai, ChengXiang.
Publicado em 2012

Impact of Rituximab (Rituxan) on the Treatment of B-Cell Non-Hodgkin’s Lymphoma

Por Dotan, Efrat, Aggarwal, Charu, Smith, Mitchell R.
Publicado em 2010

Chorioamnionitis due to Arcanobacterium haemolyticum

Por Saxena, Sonal, Aggarwal, Charu, Anuradha, Mehta, Geeta
Publicado em 2011

Antiangiogenic agents in the management of non-small cell lung cancer: Where do we stand now and where are we headed?

Por Aggarwal, Charu, Somaiah, Neeta, Simon, George R
Publicado em 2012

Immunotherapy for head and neck cancer: latest developments and clinical potential

Por Bauml, Joshua M., Cohen, Roger B., Aggarwal, Charu
Publicado no Ther Adv Med Oncol (2016)

Frequency of EGFR and KRAS Mutations in Patients with Non Small Cell Lung Cancer by Racial Background: Do Disparities exist?

Por Bauml, Joshua, Mick, Rosemarie, Zhang, Yu, Watt, Christopher D., Vachani, Anil, Aggarwal, Charu, Evans, Tracey, Langer, Corey
Publicado em 2013

Determinants of Survival in Advanced Non-Small Cell Lung Cancer (NSCLC) in the Era of Targeted Therapies

Por Bauml, Joshua, Mick, Rosemarie, Zhang, Yu, Watt, Christopher D., Vachani, Anil, Aggarwal, Charu, Evans, Tracey, Langer, Corey
Publicado em 2013

Three-arm randomized phase II study of carboplatin and paclitaxel in combination with cetuximab, cixutumumab, or both for advanced non-small cell lung cancer (NSCLC) patients who w...

Por Hanna, Nasser H., Dahlberg, Suzanne E., Kolesar, Jill, Aggarwal, Charu, Hirsch, Fred R., Ramalingam, Suresh S., Schiller, Joan H.
Publicado no Cancer (2015)

How Patients View Lung Cancer Screening. The Role of Uncertainty in Medical Decision Making

Por Schapira, Marilyn M., Aggarwal, Charu, Akers, Scott, Aysola, Jaya, Imbert, Diana, Langer, Corey, Simone, Charlie B., Strittmatter, Emily, Vachani, Anil, Fraenkel, Liana
Publicado no Ann Am Thorac Soc (2016)

Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapy

Por Brady, Anna K., McNeill, Jonathan D., Judy, Brendan, Bauml, Joshua, Evans, Tracey L., Cohen, Roger B., Langer, Corey, Vachani, Anil, Aggarwal, Charu
Publicado no Oncotarget (2015)

A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511)

Por Owonikoko, Taofeek K., Dahlberg, Suzanne E., Khan, Saad A., Gerber, David E., Dowell, Jonathan, Moss, Rebecca A., Belani, Chandra P., Hann, Christine L., Aggarwal, Charu, Ramalingam, Suresh S.
Publicado no Lung Cancer (2015)

Pretreatment red blood cell total folate is associated with response to pemetrexed in stage IV non-squamous non-small-cell lung cancer

Por Bagley, Stephen J., Vitale, Steven, Zhang, Suhong, Aggarwal, Charu, Evans, Tracey L., Alley, Evan W., Cohen, Roger B., Langer, Corey J., Blair, Ian A., Vachani, Anil, Whitehead, Alexander S.
Publicado no Clin Lung Cancer (2016)